May 24, 2024International Journal of Antimicrobial Agents3 citationsOpen Access

CRF08BC subtype is more prone to ART failure and new generation NNRTI-resistance under long-term first line ART

MWMin WuChina University of Geosciences YDYuan DongSun Yat-sen University LZLiyan ZengFudan University

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

To investigate the characteristics of drug resistance mutations (DRMs) and their contextual influence on drug susceptibility in CRF07BC and CRF₀8BC subtypes.

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo

Cite This Study

Wu et al. (Fri,) studied this question.

synapsesocial.com/papers/68e6886ab6db64358761119f https://doi.org/https://doi.org/10.1016/j.ijantimicag.2024.107215

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Thymidine analogue reverse transcriptase inhibitors resistance mutations profiles and association to other nucleoside reverse transcriptase inhibitors resistance mutations observed in the context of virological failure2003 · 119 citations
2Virological failure in patients with HIV-1 subtype C receiving antiretroviral therapy: an analysis of a prospective national cohort in Sweden2016 · 52 citations
3Rates of HIV-1 virological suppression and patterns of acquired drug resistance among fisherfolk on first-line antiretroviral therapy in Uganda2019 · 26 citations
4Prevalence of predicted resistance to doravirine in HIV-1-positive patients after exposure to non-nucleoside reverse transcriptase inhibitors2019 · 38 citations
5Differences in resistance mutations among HIV‐1 non‐subtype B infections: a systematic review of evidence (1996–2008)2009 · 83 citations

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo